Coya Therapeutics Inc (COYA)
Coya Therapeutics Market Cap: 124.25M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 124.25M |
May 15, 2024 | 122.79M |
May 14, 2024 | 120.60M |
May 13, 2024 | 118.12M |
May 10, 2024 | 120.02M |
May 09, 2024 | 123.67M |
May 08, 2024 | 117.38M |
May 07, 2024 | 118.41M |
May 06, 2024 | 121.87M |
May 03, 2024 | 126.84M |
May 02, 2024 | 128.30M |
May 01, 2024 | 126.70M |
April 30, 2024 | 132.25M |
April 29, 2024 | 122.46M |
April 26, 2024 | 125.67M |
April 25, 2024 | 123.19M |
April 24, 2024 | 122.90M |
April 23, 2024 | 117.20M |
April 22, 2024 | 116.76M |
April 19, 2024 | 116.91M |
April 18, 2024 | 123.34M |
April 17, 2024 | 120.41M |
April 16, 2024 | 119.39M |
April 15, 2024 | 122.31M |
April 12, 2024 | 131.81M |
Date | Value |
---|---|
April 11, 2024 | 133.56M |
April 10, 2024 | 135.03M |
April 09, 2024 | 136.63M |
April 08, 2024 | 140.87M |
April 05, 2024 | 139.70M |
April 04, 2024 | 133.86M |
April 03, 2024 | 144.82M |
April 02, 2024 | 145.26M |
April 01, 2024 | 143.21M |
March 28, 2024 | 144.85M |
March 27, 2024 | 140.91M |
March 26, 2024 | 129.23M |
March 25, 2024 | 129.38M |
March 22, 2024 | 141.93M |
March 21, 2024 | 144.12M |
March 20, 2024 | 144.84M |
March 19, 2024 | 146.44M |
March 18, 2024 | 143.39M |
March 15, 2024 | 147.32M |
March 14, 2024 | 145.43M |
March 13, 2024 | 142.37M |
March 12, 2024 | 131.03M |
March 11, 2024 | 141.94M |
March 08, 2024 | 135.27M |
March 07, 2024 | 129.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Virpax Pharmaceuticals Inc | 0.937M |
CEL-SCI Corp | 75.57M |
AIM ImmunoTech Inc | 19.46M |
IGC Pharma Inc | 37.97M |
NovaBay Pharmaceuticals Inc | 4.540M |
Market Cap Related Metrics
Price to Book Value | 3.836 |
Price | 8.50 |
Earnings Yield | -10.00% |